• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
With Great Hopes Come Great Expectations: Access and Adoption Issues Associated With COVID-19 Vaccines.满怀希望,满怀期待:与 COVID-19 疫苗相关的获取和采用问题。
JMIR Public Health Surveill. 2021 Aug 4;7(8):e26111. doi: 10.2196/26111.
2
People's Willingness to Vaccinate Against COVID-19 Despite Their Safety Concerns: Twitter Poll Analysis.尽管存在安全顾虑,但人们对接种 COVID-19 疫苗的意愿:Twitter 民意调查分析。
J Med Internet Res. 2021 Apr 29;23(4):e28973. doi: 10.2196/28973.
3
Socioeconomic determinants and reasons for non-acceptance to vaccination recommendations during the 3 - 5 waves of the COVID-19 pandemic in Hungary.匈牙利 COVID-19 大流行的 3-5 波期间,疫苗接种建议的社会经济决定因素和不接受原因。
BMC Public Health. 2024 Jul 5;24(1):1796. doi: 10.1186/s12889-024-19267-2.
4
COVID-19 vaccinations: The unknowns, challenges, and hopes.COVID-19 疫苗接种:未知、挑战与希望。
J Med Virol. 2022 Apr;94(4):1336-1349. doi: 10.1002/jmv.27487. Epub 2021 Dec 10.
5
Evaluating the relationship between moral values and vaccine hesitancy in Great Britain during the COVID-19 pandemic: A cross-sectional survey.评估英国在 COVID-19 大流行期间道德价值观与疫苗犹豫之间的关系:一项横断面调查。
Soc Sci Med. 2022 Sep;308:115218. doi: 10.1016/j.socscimed.2022.115218. Epub 2022 Jul 14.
6
The Worrying Phenomenon of COVID-19 Vaccine Hesitancy and Its Negative Impact on Pandemic Control Efforts: Common Themes that Emerged in the Middle East and North Africa (MENA) Region.《COVID-19 疫苗犹豫现象及其对大流行控制努力的负面影响:中东和北非(MENA)地区出现的共同主题》。
Adv Exp Med Biol. 2024;1457:299-322. doi: 10.1007/978-3-031-61939-7_17.
7
Impact of COVID-19 on vaccine confidence and uptake: A systematic literature review.新冠疫情对疫苗信心和接种率的影响:系统文献回顾。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2384180. doi: 10.1080/21645515.2024.2384180. Epub 2024 Aug 6.
8
Unfolding the Determinants of COVID-19 Vaccine Acceptance in China.揭示中国民众对新冠病毒疫苗接受度的决定因素。
J Med Internet Res. 2021 Jan 15;23(1):e26089. doi: 10.2196/26089.
9
Canadian health care providers' and education workers' hesitance to receive original and bivalent COVID-19 vaccines.加拿大卫生保健提供者和教育工作者对接种原始和二价 COVID-19 疫苗犹豫不决。
Vaccine. 2024 Oct 24;42(24):126271. doi: 10.1016/j.vaccine.2024.126271. Epub 2024 Sep 2.
10
Vaccine hesitancy in the era of COVID-19.新冠疫情时期的疫苗犹豫
Public Health. 2021 May;194:245-251. doi: 10.1016/j.puhe.2021.02.025. Epub 2021 Mar 4.

引用本文的文献

1
Understanding COVID-19 Vaccine Hesitancy among the General Population in Japan from Public Health Ethical Perspectives: Findings from a Narrative Review.从公共卫生伦理视角理解日本普通民众对新冠疫苗的犹豫态度:一项叙述性综述的结果
Asian Bioeth Rev. 2024 Oct 24;17(1):141-165. doi: 10.1007/s41649-024-00310-8. eCollection 2025 Jan.
2
COVID-19 Vaccine Hesitancy: Umbrella Review of Systematic Reviews and Meta-Analysis.COVID-19 疫苗犹豫:系统评价和荟萃分析的伞式综述。
JMIR Public Health Surveill. 2024 Apr 30;10:e54769. doi: 10.2196/54769.
3
A Review of Inactivated COVID-19 Vaccine Development in China: Focusing on Safety and Efficacy in Special Populations.中国新冠病毒灭活疫苗研发综述:聚焦特殊人群的安全性与有效性
Vaccines (Basel). 2023 May 31;11(6):1045. doi: 10.3390/vaccines11061045.
4
Pfizer-BioNTech (BNT162b2), Moderna (mRNA-1273) COVID-19 mRNA vaccines and hypersensitivity reactions.辉瑞-生物科技(BNT162b2)、莫德纳(mRNA-1273)COVID-19 mRNA 疫苗与过敏反应。
J Natl Med Assoc. 2022 Dec;114(6):601-612. doi: 10.1016/j.jnma.2022.08.003. Epub 2022 Oct 28.
5
How to boost the boosters? A survey-experiment on the effectiveness of different policies aimed at enhancing acceptance of a "Seasonal" vaccination against COVID-19.如何增强助推效果?一项旨在提高人们对季节性 COVID-19 疫苗接种接受度的不同政策效果的调查实验。
Isr J Health Policy Res. 2022 Jul 4;11(1):27. doi: 10.1186/s13584-022-00536-7.
6
COVID-19 and counterfeit vaccines: Global implications, new challenges and opportunities.新冠病毒与假冒疫苗:全球影响、新挑战与机遇
Health Policy Technol. 2022 Jun;11(2):100630. doi: 10.1016/j.hlpt.2022.100630. Epub 2022 Apr 10.
7
Mind the "Vaccine Fatigue".警惕“疫苗疲劳”。
Front Immunol. 2022 Mar 10;13:839433. doi: 10.3389/fimmu.2022.839433. eCollection 2022.
8
COVID-19 vaccine guidelines was numerous in quantity but many lack transparent reporting of methodological practices.COVID-19 疫苗指南数量众多,但许多指南在方法实践的报告方面缺乏透明度。
J Clin Epidemiol. 2022 Apr;144:163-172. doi: 10.1016/j.jclinepi.2021.12.015. Epub 2021 Dec 14.
9
Rigorous Policy-Making Amid COVID-19 and Beyond: Literature Review and Critical Insights.新冠疫情期间及之后的严谨政策制定:文献回顾与批判性洞察。
Int J Environ Res Public Health. 2021 Nov 26;18(23):12447. doi: 10.3390/ijerph182312447.
10
Technology-based interventions for nursing home residents: a systematic review protocol.基于技术的干预措施在养老院居民中的应用:系统评价方案
BMJ Open. 2021 Dec 1;11(12):e056142. doi: 10.1136/bmjopen-2021-056142.

本文引用的文献

1
Corona exhaustion (CORONEX): COVID-19-induced exhaustion grinding down humanity.新冠疲惫症(CORONEX):由新冠病毒引发的疲惫正在折磨人类。
Curr Res Behav Sci. 2021 Nov;2:100014. doi: 10.1016/j.crbeha.2021.100014. Epub 2021 Jan 13.
2
The promise and perils of Unit 731 data to advance COVID-19 research.731部队数据用于推进新冠病毒研究的前景与风险。
BMJ Glob Health. 2021 May;6(5). doi: 10.1136/bmjgh-2020-004772.
3
Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data.以色列全国疫苗接种运动后,mRNA BNT162b2疫苗对SARS-CoV-2感染及COVID-19病例、住院和死亡的影响与效果:一项利用国家监测数据的观察性研究
Lancet. 2021 May 15;397(10287):1819-1829. doi: 10.1016/S0140-6736(21)00947-8. Epub 2021 May 5.
4
Covid-19: European countries suspend use of Oxford-AstraZeneca vaccine after reports of blood clots.新冠疫情:有报道称出现血栓后,欧洲多国暂停使用牛津-阿斯利康疫苗。
BMJ. 2021 Mar 11;372:n699. doi: 10.1136/bmj.n699.
5
Severe allergic reactions after COVID-19 vaccination with the Pfizer/BioNTech vaccine in Great Britain and USA: Position statement of the German Allergy Societies: Medical Association of German Allergologists (AeDA), German Society for Allergology and Clinical Immunology (DGAKI) and Society for Pediatric Allergology and Environmental Medicine (GPA).英国和美国接种辉瑞/生物科技公司新冠疫苗后出现的严重过敏反应:德国过敏学会立场声明:德国过敏症专科医生医学协会(AeDA)、德国过敏与临床免疫学会(DGAKI)以及儿童过敏与环境医学学会(GPA)
Allergo J Int. 2021;30(2):51-55. doi: 10.1007/s40629-020-00160-4. Epub 2021 Feb 24.
6
Covid-19: How the UK vaccine rollout delivered success, so far.新冠疫情:英国疫苗接种计划目前是如何取得成功的。
BMJ. 2021 Feb 18;372:n421. doi: 10.1136/bmj.n421.
7
Reported orofacial adverse effects of COVID-19 vaccines: The knowns and the unknowns.报告的 COVID-19 疫苗的口腔颌面部不良反应:已知和未知。
J Oral Pathol Med. 2021 Apr;50(4):424-427. doi: 10.1111/jop.13165. Epub 2021 Feb 19.
8
Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Moderna COVID-19 Vaccine - United States, December 21, 2020-January 10, 2021.美国 2020 年 12 月 21 日-2021 年 1 月 10 日期间,在接种 Moderna COVID-19 疫苗第一针后出现过敏反应(包括过敏反应)。
MMWR Morb Mortal Wkly Rep. 2021 Jan 29;70(4):125-129. doi: 10.15585/mmwr.mm7004e1.
9
Vaccines are not yet a silver bullet: The imperative of continued communication about the importance of COVID-19 safety measures.疫苗并非万灵药:持续宣传新冠疫情安全措施重要性的必要性。
Brain Behav Immun Health. 2021 Mar;12:100204. doi: 10.1016/j.bbih.2021.100204. Epub 2021 Jan 20.
10
The need for a disaster readiness mindset: A key lesson from the coronavirus disease 2019 (COVID-19) pandemic.对灾难准备思维模式的需求:2019冠状病毒病(COVID-19)大流行的一个关键教训。
Infect Control Hosp Epidemiol. 2022 Apr;43(4):538-539. doi: 10.1017/ice.2021.26. Epub 2021 Jan 25.

满怀希望,满怀期待:与 COVID-19 疫苗相关的获取和采用问题。

With Great Hopes Come Great Expectations: Access and Adoption Issues Associated With COVID-19 Vaccines.

机构信息

Center on Smart and Connected Health Technologies, Mays Cancer Center, School of Nursing, UT Health San Antonio, San Antonio, TX, United States.

Department of Humanities, Institute of Technology Carlow, Carlow, Ireland.

出版信息

JMIR Public Health Surveill. 2021 Aug 4;7(8):e26111. doi: 10.2196/26111.

DOI:10.2196/26111
PMID:33560997
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8341090/
Abstract

Although COVID-19 vaccines are becoming increasingly available, their ability to effectively control and contain the spread of the COVID-19 pandemic is highly contingent on an array of factors. This paper discusses how limitations to vaccine accessibility, issues associated with vaccine side effects, concerns regarding vaccine efficacy, along with the persistent prevalence of vaccine hesitancy among the public, including health care professionals, might impact the potential of COVID-19 vaccines to curb the pandemic. We draw insights from the literature to identify practical solutions that could boost people's adoption of COVID-19 vaccines and their accessibility. We conclude with a discussion on health experts' and government officials' moral and ethical responsibilities to the public, even in light of the urgency to adopt and endorse "the greatest amount of good for the greatest number" utilitarian philosophy in controlling and managing the spread of COVID-19.

摘要

尽管 COVID-19 疫苗的供应日益增加,但它们有效控制和遏制 COVID-19 大流行传播的能力高度依赖于一系列因素。本文讨论了疫苗可及性的限制、与疫苗副作用相关的问题、对疫苗效力的担忧,以及公众(包括医疗保健专业人员)对疫苗的持续犹豫,这些因素可能会影响 COVID-19 疫苗遏制大流行的潜力。我们从文献中汲取见解,以确定可提高人们对 COVID-19 疫苗的接受度和可及性的实际解决方案。最后,我们讨论了健康专家和政府官员对公众的道德和伦理责任,即使在紧急情况下,也需要采用和支持“为最多数人谋求最大利益”的功利主义哲学来控制和管理 COVID-19 的传播。